Bcal Diagnostics Ltd (BDX) — Capital Reinvestment Ratio

Latest as of December 2020: 0.02x

Bcal Diagnostics Ltd (BDX) has a Capital Reinvestment Ratio of 0.02x as of December 2020, meaning it reinvests 0% of its operating cash flow (AU$118.98K) in capital expenditures (AU$1.93K). See Bcal Diagnostics Ltd (BDX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

AU$118.98K

AUD

Capital Expenditures

AU$1.93K

AUD

Data as of

Dec 2020

Most recent filing

Annual Capital Reinvestment Ratio for Bcal Diagnostics Ltd (None–None)

Year-by-year Capital Reinvestment Ratio for Bcal Diagnostics Ltd from None to None. For live market cap and broader valuation context, see Bcal Diagnostics Ltd market cap and net worth.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow